Results from the present work demonstrate that ovarian cancer cell lines expressing high HYAL-1 levels, e.g. derived from clear cell and mucinous EOCs (Fig. 1), have low mRNA expression of ERα, ERβ and PR (Fig. 3). This evidence concerns the gene HYAL1 and ovarian cancer.